Want to join the conversation?
Global pharmaceutical company $MYL said it launched its Almotriptan Tablets USP, 6.25 mg & 12.5 mg, the generic version of migraine drug Axert, in the U.S. $MYL said it had received final FDA approval for its abbreviated new drug application for the product that is used for the acute treatment of migraine attacks in adults.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.